Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer.
Wang J, Xiu J, Baca Y, Battaglin F, Arai H, Kawanishi N, Soni S, Zhang W, Millstein J, Salhia B, Goldberg RM, Philip PA, Seeber A, Hwang JJ, Shields AF, Marshall JL, Astsaturov I, Craig Lockhart A, Gatalica Z, Michael Korn W, Lenz HJ.
Wang J, et al. Among authors: gatalica z.
Oncogene. 2021 Jul;40(30):4894-4905. doi: 10.1038/s41388-021-01840-3. Epub 2021 Jun 23.
Oncogene. 2021.
PMID: 34163031